Antti Sajantila

Person

Latest publications

  1. Exploring the 1000 Genomes Project haplotype reporting for the CYP2D6 pharmacogene

    Wendt, F. R., Woerner, A. E., Sajantila, A., Moura-Neto, R. S. & Budowle, B., May 2019, In : International Journal of Legal Medicine. 133, 3, p. 807-810 4 p.

    Research output: Contribution to journalLetterScientificpeer-review

  2. Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions

    Rahikainen, A-L., Vauhkonen, P., Pett, H., Palo, J. U., Haukka, J., Ojanperä, I., Niemi, M. & Sajantila, A., Mar 2019, In : International Journal of Legal Medicine. 133, 2, p. 353-363 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Supervised Classification of CYP2D6 Genotype and Metabolizer Phenotype With Postmortem Tramadol-Exposed Finns

    Wendt, F. R., Novroski, N. M. M., Rahikainen, A-L., Sajantila, A. & Budowle, B., Mar 2019, In : The American Journal of Forensic Medicine and Pathology. 40, 1, p. 8-18 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (149) »

Latest activities

  1. Ethical, legal and practical aspects of post-mortem genetic analysis for sudden cardiac death in young adults

    Antti Sajantila (Speaker: Presenter)
    23 Nov 201625 Nov 2016

    Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

  2. Helsingin yliopisto, lääketieteellinen tiedekunta (External organisation)

    Antti Sajantila (Member)
    14 Feb 2013

    Activity: Membership typesMembership or other role in review committee

  3. Libyan väliaikaishallinnon ministeriöt

    Antti Sajantila (Other role)
    9 Apr 201218 Apr 2012

    Activity: Visiting an external institution typesAcademic visit to other institution

View all (3) »

ID: 80381